FI94591C - Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi - Google Patents

Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi Download PDF

Info

Publication number
FI94591C
FI94591C FI891145A FI891145A FI94591C FI 94591 C FI94591 C FI 94591C FI 891145 A FI891145 A FI 891145A FI 891145 A FI891145 A FI 891145A FI 94591 C FI94591 C FI 94591C
Authority
FI
Finland
Prior art keywords
lysine
acid
active ingredients
fatty acids
dha
Prior art date
Application number
FI891145A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI891145L (fi
FI891145A0 (fi
FI94591B (fi
Inventor
Ti Nagy P Ter Liter
M Ria Boros
Jenoe Szilbereky
Cz Istv N R
Gyoengyv R Soos
Miklos Koller
R Al N Pint
Meth G Bor N
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of FI891145A0 publication Critical patent/FI891145A0/fi
Publication of FI891145L publication Critical patent/FI891145L/fi
Application granted granted Critical
Publication of FI94591B publication Critical patent/FI94591B/fi
Publication of FI94591C publication Critical patent/FI94591C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI891145A 1988-03-09 1989-03-09 Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi FI94591C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition
HU113288 1988-03-09

Publications (4)

Publication Number Publication Date
FI891145A0 FI891145A0 (fi) 1989-03-09
FI891145L FI891145L (fi) 1989-09-10
FI94591B FI94591B (fi) 1995-06-30
FI94591C true FI94591C (fi) 1995-10-10

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891145A FI94591C (fi) 1988-03-09 1989-03-09 Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi

Country Status (14)

Country Link
JP (1) JPH01316316A (cs)
KR (1) KR890014103A (cs)
BE (1) BE1002890A3 (cs)
CA (1) CA1334576C (cs)
CH (1) CH678918A5 (cs)
DE (1) DE3907649C2 (cs)
FI (1) FI94591C (cs)
FR (1) FR2628324B1 (cs)
GB (1) GB2216418B (cs)
HU (1) HU209973B (cs)
IT (1) IT1229562B (cs)
LU (1) LU87471A1 (cs)
NL (1) NL8900574A (cs)
SE (1) SE8900828L (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
WO1996030381A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
US20090192226A1 (en) * 2007-12-17 2009-07-30 Josef Neu Materials and Methods for Treatment of Pathological Ocular Vascular Proliferation
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
PL3463310T3 (pl) * 2016-05-25 2023-12-04 Evonik Operations Gmbh Tabletki o wysokiej zawartości składników aktywnych soli aminokwasowych kwasów tłuszczowych omega-3
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
JP7050148B2 (ja) 2017-08-15 2022-04-07 エボニック オペレーションズ ゲーエムベーハー オメガ-3脂肪酸アミノ酸塩の有効成分含有量が高い錠剤
WO2021023857A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
US20220280387A1 (en) 2019-08-08 2022-09-08 Evonik Operations Gmbh Down streaming process for the production of polyunsaturated fatty acid salts
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (cs) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
AU596880B2 (en) * 1986-09-17 1990-05-17 Clintec Nutrition Company Liquid nutritional compositions
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
FI891145L (fi) 1989-09-10
NL8900574A (nl) 1989-10-02
SE8900828D0 (sv) 1989-03-09
KR890014103A (ko) 1989-10-21
CA1334576C (en) 1995-02-28
IT1229562B (it) 1991-09-04
LU87471A1 (fr) 1990-10-02
IT8919704A0 (it) 1989-03-09
DE3907649C2 (de) 1996-07-11
SE8900828L (sv) 1989-09-10
CH678918A5 (cs) 1991-11-29
FR2628324B1 (fr) 1994-05-27
JPH01316316A (ja) 1989-12-21
FI891145A0 (fi) 1989-03-09
BE1002890A3 (fr) 1991-07-16
FR2628324A1 (fr) 1989-09-15
GB2216418B (en) 1991-12-11
DE3907649A1 (de) 1989-09-28
FI94591B (fi) 1995-06-30
HU209973B (en) 1995-01-30
HUT60432A (en) 1992-09-28
GB8905385D0 (en) 1989-04-19
GB2216418A (en) 1989-10-11

Similar Documents

Publication Publication Date Title
FI94591C (fi) Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi
Stokes et al. MICROBIOLOGICAL METHODS FOR THE DETERMINATION OF AMINO ACIDS: II. A UNIFORM ASSAY FOR THE TEN ESSENTIAL AMINO ACIDS
FI93949C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
JPH01121300A (ja) 乳汁に由来するポリペプチド成長因子
US5869714A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
Buchmüller-Rouiller et al. Macrophage activation for intracellular killing as induced by calcium ionophore. Correlation with biologic and biochemical events
Ivanovska et al. Influence of cinnamic acid on lymphocyte proliferation, cytokine release and Klebsiella infection in mice
US20220273597A1 (en) Agent for preventing, ameliorating, or treating periodontal disease
CN110650970A (zh) 抗菌肽及其药品
SE8406555D0 (sv) A process for obtaining ready-for-fertilization sexual products from sexually mature fish
US6469137B1 (en) Myelopeptides and their therapeutic use
KR101263963B1 (ko) 항바이러스 및 면역자극 해산 어류 오일 조성물
DE68907268D1 (de) Verwendung von phytinsaeure als antidot gegen alkoholvergiftung.
Funk et al. Utilization of the L-and DL-isomers of α-keto-β-methylvaleric acid by rats and comparative efficacy of the keto analogs of branched-chain amino acids provided as ornithine, lysine and histidine salts
Ash et al. Impact of Nippostrongylus brasiliensis (Nematoda) on the serum albumin and amino acid concentrations of rats fed adequate or protein-deficient diets
KR100346334B1 (ko) 스코폴레틴으로 이루어진 염증 치료용 약제 조성물
FR2691153A1 (fr) Dodécapeptides monomère et dimère, utilisation en tant qu'agents anti-mégacaryocytaires.
JPH04330095A (ja) 生理活性ポリペプチド、その製造法および抗菌剤
JPH04330096A (ja) 生理活性ポリペプチド、その製造方法および抗菌剤

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: BIOREX KFT